Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Glyn John Truscott has worked on the following 41 EPO patent applications which have been published in the last five years:

EP11822584

PROSTHETIC TISSUE VALVE

IPC classification:
A61F 2/24
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12751893

MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS

IPC classification:
C07K 14/47, C07K 14/485, C07K 14/605, C07K 14/76, C07K 16/00, C07K 16/18, C07K 16/30, C07K 19/00
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12844433

HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12845801

STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13740871

HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN

IPC classification:
A61K 39/395, C07K 16/00, C12P 21/08
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13749143

PHENOTYPE PROFILE OF HUMAN RETINAL PROGENITOR CELLS

IPC classification:
C12N 5/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13716352

STEM CELL MICROPARTICLES

IPC classification:
A61K 31/711, A61P 9/00, A61P 11/00, A61P 25/28, C12N 5/0797
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13788302

HETEROMULTIMER CONSTRUCTS OF IMMUNOGLOBULIN HEAVY CHAINS WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02, C07K 16/12, C07K 16/24, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13742261

STEM CELL MICROPARTICLES

IPC classification:
A61K 31/711, A61K 35/30, A61P 9/00, A61P 11/00, A61P 25/28, C12N 5/0797
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13839811

METHOD AND SYSTEM FOR TREATMENT OF BIOLOGICAL TISSUE

IPC classification:
A61K 35/12
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Multiple attorneys, Elkington and Fife LLP
Agent:
Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13843363

METHODS OF QUANTITATING HEAVY AND LIGHT CHAIN POLYPEPTIDE PAIRS

IPC classification:
A61K 39/00, C12N 5/07, C12N 5/16
Applicant:
Zymeworks Inc
Applicant:
National Research Council of Canada
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13855452

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING SINGLE MOLECULE DETECTION

IPC classification:
G06F 19/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13858496

ENGINEERED IMMUNOGLOBULIN HEAVY CHAIN-LIGHT CHAIN PAIRS AND USES THEREOF

IPC classification:
C07K 16/00, C07K 16/46, C12N 5/10, C12N 15/13, C12Q 1/68, G06F 19/10
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14746114

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT

IPC classification:
A61K 31/395, C07K 16/00, C07K 16/26
Applicant:
Amgen Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14706666

STEM CELL MICROPARTICLES AND MIRNA

IPC classification:
A61K 31/711, A61K 35/30, A61P 9/00, A61P 11/00, A61P 25/28
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14708317

METHOD OF PRODUCING MICROPARTICLES

IPC classification:
A61K 31/711, A61K 35/30, A61P 9/00, A61P 11/00, A61P 25/28, C12N 5/0797, C12N 5/10
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14756908

HIV ANTIGENS AND ANTIBODIES

IPC classification:
A61K 39/395
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11761857

ANTIBODIES WITH ENHANCED OR SUPPRESSED EFFECTOR FUNCTION

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 14/735, C07K 16/00, C07K 16/28, C07K 19/00, C12N 15/13, G06F 19/10
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14778467

SYSTEM AND METHOD FOR MONITORING PHYSIOLOGICAL CHARACTERISTICS

IPC classification:
A61B 5/0205, A61B 5/05, A61B 5/11
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP11837370

STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/06, C07K 16/00, C07K 16/32, C07K 16/46, C12N 15/13
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14782299

WIRELESS CONTROL SYSTEM FOR PERSONAL COMMUNICATION DEVICE

IPC classification:
H04R 25/00
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14803370

HETEROMULTIMERS WITH REDUCED OR SILENCED EFFECTOR FUNCTION

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/28, C07K 16/46, C12N 15/13
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15181464

FRATAXIN MUTANTS

IPC classification:
C07K 14/47
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14837796

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING ELECTRICAL METHODS

IPC classification:
C40B 20/04
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14848888

METHODS FOR TREATING HEMATOLOGIC CANCERS

IPC classification:
C07K 16/28
Applicant:
The Medical College of Wisconsin, Inc.
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14790257

STEM CELL MICROPARTICLES AND MIRNA

IPC classification:
A61K 35/30, A61P 35/00, C12N 5/0797
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14830928

ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES

IPC classification:
B01L 3/00, C12N 15/10, C12Q 1/68
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15737348

ACTIVIN INHIBITOR RESPONSE PREDICTION AND USES FOR TREATMENT

IPC classification:
C12Q 1/68
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15703384

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Novartis AG
Applicant:
President and Fellows of Harvard College
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15705163

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Novartis AG
Applicant:
Children's Medical Center Corporation
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15799575

MODIFIED ANTIGEN BINDING POLYPEPTIDE CONSTRUCTS AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/46, C12N 15/13
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15713290

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14887019

ARTIFICIAL SKELETAL MATERIAL AND CONSTRUCTS FORMED THEREFROM

IPC classification:
A61B 17/58, A61F 2/28, A61K 38/18
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16178026

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 5/06, A61P 9/10, A61P 35/00, A61P 37/00, A61P 43/00, C07K 16/22, C12N 15/13
Applicant:
Amgen Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
APPLICATION PUBLISHED
EP15799583

CHLORIDE SALT OF TAT-NR2B9C

IPC classification:
A61K 9/19, A61K 38/16, A61P 9/10, C07K 7/06, C07K 7/08, C07K 14/16, C07K 14/705, C07K 19/00
Applicant:
Nono Inc.
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15800695

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

IPC classification:
A61K 9/19, A61K 38/16, A61P 9/10, C07K 7/06, C07K 7/08, C07K 14/16, C07K 14/705, C07K 19/00
Applicant:
Nono Inc.
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15824932

TREATMENT AND PREVENTION OF THE COMMON COLD USING POVIDONE-IODINE

IPC classification:
A61K 31/79, A61K 33/18, A61P 11/00, A61P 31/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15767683

COMBINATION THERAPIES

IPC classification:
A61K 31/506, A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
Request for examination was made
EP15842621

METHODS AND COMPOSITIONS FOR TREATING PSYCHOTIC DISORDERS

IPC classification:
A61P 25/18
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
Request for examination was made
EP15784907

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/46
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Novartis AG
Applicant:
President and Fellows of Harvard College
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
Request for examination was made
EP15834953

METHODS OF SCREENING FOR DRUGS TO PREVENT NOISE-INDUCED HEARING LOSS

IPC classification:
A61B 5/12, A61K 38/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
Request for examination was made

Please Sign in to use this feature